{"url_path":"/sec/cochw/8-k/2026-05-18/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 ** **Submission of Matters to a Vote of Security Holders.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-058429-index.html","accession_number":"0001213900-26-058429","cik":"0001840877","ticker":"COCH","issuer_name":"Envoy Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-058429-index.html","primary_entity_key":"0001840877","primary_entity_name":"Envoy Medical, Inc."},"word_count":371,"has_tables":true,"body_markdown":"** **\n\n**Item 5.07** **Submission of Matters to a Vote of Security Holders.**\n\n \n\nAt the Annual Meeting:\n\n \n\n1.The Company’s stockholders elected two Class III director nominees, Brent T. Lucas and Susan J.\nKantor, to the Company’s Board of Directors to hold office until the earlier of the 2029 annual meeting of stockholders, the election\nof such director’s successor, or such director’s death, resignation or removal;\n\n \n\n2.Stockholders ratified the appointment of EisnerAmper, LLP as the Company’s independent registered\npublic accounting firm for the fiscal year ending December 31, 2026;\n\n \n\n3.Stockholders approved, on a non-binding and advisory basis, the compensation of the Company’s named\nexecutive officers;\n\n \n\n4.Stockholders approved an amendment to the Equity Incentive Plan to authorize an additional 6,000,000 shares\nof Common Stock for issuance under such plan;\n\n \n\n5.Stockholders approved an amendment to the Employee Stock Purchase Plan to authorize an additional 1,200,000 shares\nof Common Stock for issuance under such plan; and\n\n \n\n6.Stockholders approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance\nof warrants to purchase shares of the Common Stock, and the issuance of Class A Common Stock underlying such warrants, that were\nissued in a transaction that was completed on February 12, 2026.\n\n \n\n1\n\n \n\n \n\nThe voting results for each such matter were as follows:\n\n \n\n1.Election of directors:\n\n \n\nNominee: \nFor: \nWithheld: \nBroker Non-Votes:\n\nBrent T. Lucas \n47,216,205 \n70,530 \n655,966\n\nSusan J. Kantor \n46,961,571 \n325,164 \n655,966\n\n \n\n2.Ratification of the appointment of EisnerAmper, LLP as the Company’s independent registered public\naccounting firm for the fiscal year ending December 31, 2026:\n\n \n\nFor: \nAgainst: \nAbstain:\n\n47,933,597 \n3,434 \n5,670\n\n \n\n3.Approval, on a non-binding and advisory basis, of the Company’s named executive officer compensation:\n\n \n\nFor: \nAgainst: \nAbstain: \nBroker Non-Votes:\n\n47,144,585 \n110,476 \n31,674 \n655,966\n\n \n\n4.To approve an amendment to the Equity Incentive Plan.\n\n \n\nFor: \nAgainst: \nAbstain: \nBroker Non-Votes:\n\n46,609,864 \n624,758 \n52,113 \n655,966\n\n \n\n5.To approve an amendment to the Employee Stock Purchase Plan.\n\n \n\nFor: \nAgainst: \nAbstain: \nBroker Non-Votes:\n\n47,152,146 \n86,804 \n47,785 \n655,966\n\n \n\n6.Stockholders approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance\nof warrants to purchase shares of the Common Stock and the issuance of Common Stock underlying such warrants, that were issued in a transaction\nthat was completed on February 12, 2026.\n\n \n\nFor: \nAgainst: \nAbstain: \nBroker Non-Votes:\n\n47,217,476.89 \n42,625 \n26,634 \n655,966"}